USPCM
BIOSW

Union Square Park Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Union Square Park Capital Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,000
Closed -$2K – 70
2022
Q3 		$2K Hold
25,000
– – ﹤0.01% 76
2022
Q2 		$3K Hold
25,000
– – ﹤0.01% 103
2022
Q1 		$6K Buy
+25,000
New +$6.49K ﹤0.01% 115

Other funds holding BIOSW

MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Union Square Park Capital Management's BIOSW Position: Q4 2022 in Review

Union Square Park Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2022, closing a stake of 25,000 shares — an estimated $2K sold.

Union Square Park Capital Management first reported a position in BIOSW in Q1 2022 and held it in 3 quarters. The position peaked at $6K in Q1 2022. 45 funds tracked by Wall St. Rank hold BIOSW as of Q4 2022.

  • Union Square Park Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
  • Union Square Park Capital Management sold 25,000 BioPlus Acquisition Corp. Warrants shares in Q4 2022, an estimated $2K.
  • Union Square Park Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 3 quarters.
  • Union Square Park Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $6K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2022.

Based on Union Square Park Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.